Dr. Mehmet Furkan Burak, MD
Claim this profileMore about Mehmet Furkan Burak, MD
Clinical Trial Related
3 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical Trials
Treatments Mehmet Furkan Burak, MD has experience with
- Palmitoleic Acid
- Placebo
Breakdown of trials Mehmet Furkan Burak, MD has run
Insulin Resistance
Incretin Hormones in Polycystic Ovary Syndrome
Childhood Obesity
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Mehmet Furkan Burak, MD specialize in?
Mehmet Furkan Burak, MD focuses on Insulin Resistance and Incretin Hormones in Polycystic Ovary Syndrome. In particular, much of their work with Insulin Resistance has involved treating patients, or patients who are undergoing treatment.
Is Mehmet Furkan Burak, MD currently recruiting for clinical trials?
No, Mehmet Furkan Burak, MD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Mehmet Furkan Burak, MD has studied deeply?
Yes, Mehmet Furkan Burak, MD has studied treatments such as Palmitoleic acid, Placebo.
What is the best way to schedule an appointment with Mehmet Furkan Burak, MD?
Apply for one of the trials that Mehmet Furkan Burak, MD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.